Figure 2From: The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients Average health care costs (annualized baseline and 12 month follow-up). Differences in costs between baseline and follow-up were statistically significant (p < 0.001) for all categories, with the exception of ER costs (p = 0.700). Bars represent standard deviation.Back to article page